Company Search:
Advanced Search
Sponsored Links
CO.DON AG Company Snapshot
CO.DON AG operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares CO.DON AG with three other pharmaceutical manufacturers in Europe: Curasan AG (2018 sales of 5.84 million Euro [US$6.50 million] ), Erytech Pharma SA of France (4.45 million Euro [US$4.95 million] of which 100% was Pharmacy), and Medincell SA which is also based in France (6.44 million Euro [US$7.16 million] ).

Sales Analysis. CO.DON AG reported sales of 5.65 million Euro (US$6.29 million) for the year ending December of 2018. This represents a decrease of 5.2% versus 2017, when the company's sales were 5.96 million Euro.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
  Stock Performance Chart for CO.DON AG
  Stock Data: Recent Stock Performance:
  Current Price (1/10/2020): 1.93
(Figures in Euro)
1 Week -4.7%   13 Weeks -12.1%  
4 Weeks -24.9%   52 Weeks -42.7%  
CO.DON AG Key Data:
  Ticker: CNWK Country: Germany
  Exchanges: FRA OTH Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2018 Sales 5,654,000
(Year Ending Jan 2019).
Employees: 94
  Currency: Euro Market Cap: 42,093,612
  Fiscal Yr Ends: December Shares Outstanding: 21,866,811
  Share Type: Stammaktie Closely Held Shares: 10,545,049
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.